Kalbe Farma Tbk. (KLBF) Stock Price, Fundamentals & Analysis

What KLBF does

Kalbe Farma Tbk. (KLBF) is a large-cap healthcare stock listed on the Indonesia Stock Exchange stocks. Together with its subsidiaries, the company develops, manufactures, and trades pharmaceutical products in Indonesia. It operates through four segments: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistics. Its product range spans ethical prescription drugs, consumer health items, nutritionals, health screening services, medical devices, biopharma, animal health, and E-health products, as well as distribution and advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Key numbers explained

• The current share price is 735 IDR, with 0% price change today, meaning the stock closed flat on the session.
• The trailing P/E ratio of 9.2 and the forward P/E ratio of 9.8 show how the market values the company relative to its recent and expected earnings, respectively.
• The dividend yield of 2.72% indicates the annual dividend payout as a percentage of the current share price, with the ex-dividend date set for 4 iun. 2026.
• The beta of -0.07 suggests the stock's returns have historically moved in the opposite direction of the broader market, though the magnitude is very small.
• The price-to-book ratio of 1.37 compares the market price to the company's book value per share.
• The debt-to-equity ratio of 3.2% measures financial leverage, showing the proportion of debt used relative to shareholders' equity.

What to watch

• Revenue growth, at 18.2% year over year, is a key driver of long-term value; compare it with peers such as Fosun Pharmaceutical (600196) for context.
• Profit margin of 9.6% and operating margin of 11.9% show how efficiently the company converts sales into profit.
• The 52-week price range of 630 – 1,345 IDR and the -34.4% price change over the last year highlight the stock's recent volatility.
• The return on equity of 14.8% measures how effectively management uses shareholder capital to generate earnings.
• The share of earnings paid out as dividends is 25%, which determines the sustainability of the current payout.
• The company is part of the LQ45, a benchmark index of the Indonesia Stock Exchange.